Aromatase inhibitors and risk of cardiovascular events in breast cancer patients: a systematic review and meta-analysis

Abstract Background Cardiovascular events (CVEs) was considered as one of the primary cause to reduce the quality of life in breast cancer patients with aromatase inhibitors (AIs) treatment, which has not been sufficiently addressed. The aim of this study was to assess the correlation between risk o...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Yang He, Jianhua Zhang, Guofang Shen, Lin Liu, Qingwei Zhao, Xiaoyang Lu, Hongyu Yang, Dongsheng Hong
Формат: Artigo
Язык:Inglês
Опубликовано: BMC 2019-10-01
Серии:BMC Pharmacology and Toxicology
Предметы:
Breast cancer
Aromatase inhibitors
Cardiovascular events
Meta-analysis
Online-ссылка:http://link.springer.com/article/10.1186/s40360-019-0339-1
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы